Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification

INTRODUCTION: Accurate determination of human epidermal growth factor receptor 2 (HER2) status is essential for optimal patient management with trastuzumab (Herceptin). However, standard guidelines do not specify a particular commercial kit, antibody or probe for testing, and discrepancies arise fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Cayre, Anne, Mishellany, Florence, Lagarde, Nicole, Penault-Llorca, Frédérique
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242659/
https://www.ncbi.nlm.nih.gov/pubmed/17908324
http://dx.doi.org/10.1186/bcr1770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242659/
https://www.ncbi.nlm.nih.gov/pubmed/17908324
http://dx.doi.org/10.1186/bcr1770

Ejemplares similares